Tradestie Institutional Equity Comparison Engine
ZSPC vs BHST โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BHST Overall Edge
BHST Captures Institutional Edge (2โ0 Pillars ยท 6โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to BioHarvest Sciences Inc. Common Stock (BHST) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, ZSPC trades at N/M Forward P/E with -116.2% operating margin (-43.2% YoY revenue) versus BHST at N/M Forward P/E and -18.0% operating margin (+3.8% YoY). In options structure, ZSPC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BHST sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
ZSPC N/M vs BHST N/M Fwd P/E
Growth & Margin Winner
BHST
Op Margin -116.2% vs -18.0% ยท YoY -43.2% vs +3.8%
Momentum & Technical Winner
BHST
1Y -97.6% vs -79.4% ยท 52W Pos 2% vs 6%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
ZSPC
NASDAQ
zSpace, Inc. Common stock
Services-Prepackaged Software
$0.24
-45.79% 1D
Market Cap
$1.3M
1M Return
+71.07%
1Y Return
-97.58%
Forward P/E
N/M
Unified AI Score
59.8 / 100
HOLD
Tech 60.0
Fund 57.0
Flow 50.0
Mom 58.5
BHST
NASDAQ
BioHarvest Sciences Inc. Common Stock
Pharmaceutical Preparations
$1.30
-1.52% 1D
Market Cap
$29.9M
1M Return
-22.62%
1Y Return
-79.4%
Forward P/E
N/M
Unified AI Score
58.2 / 100
HOLD
Tech 75.0
Fund 57.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
ZSPC -97.58%
BHST -79.4%
Spread: +30.61 pp (BHST Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | ZSPC Revenue | BHST Revenue | ZSPC Op. Margin | BHST Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2023 | N/A | $10M | N/A | -78.6% | BHST |
| FY2024 | $40M | $30M | -46.3% | -27.7% | BHST |
| FY2025 | $30M | $30M | -79.5% | -16.2% | BHST |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | ZSPC | BHST | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.3M | $29.9M | Larger Scale | BHST |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -43.2% | +3.8% | Higher Growth | BHST |
| Operating Margin (TTM) Profitability | -116.2% | -18.0% | Higher Margin | BHST |
| Net Profit Margin Profitability | -91.1% | -31.2% | Higher Margin | BHST |
| Return on Equity (ROE) Capital Efficiency | 0.0% | -142.5% | Higher ROE | ZSPC |
| 52-Week Range Position Momentum | 2% ($0โ$10) | 6% ($1โ$7) | Stronger Trend | BHST |
| Beta / 30D Volatility Risk Regime | -10.63ฮฒ ยท 6994% Vol | 0.25ฮฒ ยท 86% Vol | Lower Realized Risk | BHST |
| Unified Institutional Score Composite Signal | 59.8 / 100 (HOLD) | 58.2 / 100 (HOLD) | Higher Composite | ZSPC |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full ZSPC vs BHST Buy Guide
ZSPC
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
BHST
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither ZSPC nor BHST registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.